Antimicrobial resistance (AMR) in sub-Saharan African healthcare facilities has reached critical levels according to a meta-analysis published in The Lancet Infectious Diseases. The study, which compiled antimicrobial susceptibility data from 200 hospitals across 15 countries, reveals that carbapenem resistance rates — for last-resort antibiotics — exceed 30% in healthcare facilities in the Great Lakes region and coastal West Africa. The most concerning pathogens identified by the study include carbapenem-resistant Klebsiella pneumoniae (34% average prevalence), multidrug-resistant Acinetobacter baumannii (45% of isolates in intensive care units), and methicillin-resistant Staphylococcus aureus (MRSA, 28% of hospital isolates). These figures place sub-Saharan Africa among the most affected regions globally. Professor Yewande Alimi, head of the AMR program at Africa CDC, described these findings as "a silent crisis that kills more than HIV and malaria combined in some hospital settings." She emphasized that the lack of clinical microbiology laboratories — fewer than 20% of district hospitals have them — contributes to underestimating the true scale of the problem. The study recommends the urgent implementation of antimicrobial stewardship programs in all referral hospitals, strengthening microbiological diagnostic capacity, and adopting infection prevention protocols adapted to resource-limited settings. A $75 million fund has been proposed to support these interventions over a five-year period.